Role of green tea catechins in prevention of age-related cognitive decline: Pharmacological targets and clinical perspective
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of green tea catechins in prevention of age-related cognitive decline: Pharmacological targets and clinical perspective
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-09-06
DOI
10.1002/jcp.27289
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Understanding the Broad-Spectrum Neuroprotective Action Profile of Green Tea Polyphenols in Aging and Neurodegenerative Diseases
- (2018) Silvia A. Mandel et al. JOURNAL OF ALZHEIMERS DISEASE
- Treatment of Alzheimer's Disease with the GSK-3 Inhibitor Tideglusib: A Pilot Study
- (2018) Teodoro del Ser et al. JOURNAL OF ALZHEIMERS DISEASE
- A Longitudinal Follow-Up of 550 Mild Cognitive Impairment Patients: Evidence for Large Conversion to Dementia Rates and Detection of Major Risk Factors Involved
- (2018) Ana Espinosa et al. JOURNAL OF ALZHEIMERS DISEASE
- Aromatherapy and Aromatic Plants for the Treatment of Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease: Clinical Evidence and Possible Mechanisms
- (2017) Damiana Scuteri et al. Evidence-based Complementary and Alternative Medicine
- Insulin deficiency: A possible link between obesity and cognitive function
- (2017) Ghazaleh Nameni et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE
- Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model
- (2017) Zhong-Hao Zhang et al. JOURNAL OF NEUROSCIENCE
- Role of neuroinflammation in neurodegeneration: new insights
- (2017) Róisín M. McManus et al. Alzheimers Research & Therapy
- Metabolic Syndrome and Cognitive Impairment: Current Epidemiology and Possible Underlying Mechanisms
- (2017) Francesco Panza et al. JOURNAL OF ALZHEIMERS DISEASE
- Detection and Prevention of Cognitive Decline
- (2016) Gary W. Small AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Nitric oxide pathway activity modulation alters the protective effects of (−)Epigallocatechin-3-gallate on reserpine-induced impairment in rats
- (2016) Cheng-Neng Chen et al. BEHAVIOURAL BRAIN RESEARCH
- In Silico Analysis of Green Tea Polyphenols as Inhibitors of AChE and BChE Enzymes in Alzheimer’s Disease Treatment
- (2016) Babar Ali et al. CNS & Neurological Disorders-Drug Targets
- Serotonin 5-HT6 Receptor Antagonists in Alzheimer’s Disease: Therapeutic Rationale and Current Development Status
- (2016) Hilda Ferrero et al. CNS DRUGS
- Epigallocatechin gallate attenuates amyloid β-induced inflammation and neurotoxicity in EOC 13.31 microglia
- (2016) James Cheng-Chung Wei et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The Roles of Exercise and Yoga in Ameliorating Depression as a Risk Factor for Cognitive Decline
- (2016) Danielle C. Mathersul et al. Evidence-based Complementary and Alternative Medicine
- Targeting mTOR to reduce Alzheimer-related cognitive decline: from current hits to future therapies
- (2016) Antonella Tramutola et al. Expert Review of Neurotherapeutics
- Cancer Preventive Activities of Tea Catechins
- (2016) Chung Yang et al. MOLECULES
- Beneficial Effects of Tea and the Green Tea Catechin Epigallocatechin-3-gallate on Obesity
- (2016) Takuji Suzuki et al. MOLECULES
- The therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease
- (2016) John Grizzanti et al. NUTRITION RESEARCH
- Phytochemicals as future drugs for Parkinson’s disease: a comprehensive review
- (2016) Zahra Shahpiri et al. REVIEWS IN THE NEUROSCIENCES
- A mechanistic review on plant-derived natural compounds as dietary supplements for prevention of inflammatory bowel disease
- (2016) Mohammad Hosein Farzaei et al. Expert Review of Gastroenterology & Hepatology
- Targeting mTOR to reduce Alzheimer-related cognitive decline: from current hits to future therapies
- (2016) Antonella Tramutola et al. Expert Review of Neurotherapeutics
- Age-associated Cognitive Decline: Insights into Molecular Switches and Recovery Avenues
- (2016) Arpita Konar et al. Aging and Disease
- Vascular contributions to cognitive impairment and dementia including Alzheimer's disease
- (2015) Heather M. Snyder et al. Alzheimers & Dementia
- MIND diet slows cognitive decline with aging
- (2015) Martha Clare Morris et al. Alzheimers & Dementia
- Neuroprotective Properties of the Standardized Extract fromCamellia sinensis(Green Tea) and Its Main Bioactive Components, Epicatechin and Epigallocatechin Gallate, in the 6-OHDA Model of Parkinson’s Disease
- (2015) Natália Bitu Pinto et al. Evidence-based Complementary and Alternative Medicine
- The preventive and therapeutic potential of natural polyphenols on influenza
- (2015) Roodabeh Bahramsoltani et al. Expert Review of Anti-Infective Therapy
- Polyphenon E, non-futile at neuroprotection in multiple sclerosis but unpredictably hepatotoxic: Phase I single group and phase II randomized placebo-controlled studies
- (2015) Jesus Lovera et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Dietary (−)-epicatechin as a potent inhibitor of βγ-secretase amyloid precursor protein processing
- (2015) Carla J. Cox et al. NEUROBIOLOGY OF AGING
- (−)Epigallocatechin-3-gallate decreases the stress-induced impairment of learning and memory in rats
- (2015) Hung-Sheng Soung et al. NEUROSCIENCE LETTERS
- Effects of green tea consumption on cognitive dysfunction in an elderly population: a randomized placebo-controlled study
- (2015) Kazuki Ide et al. Nutrition Journal
- Role of dietary polyphenols in the management of peptic ulcer
- (2015) Mohammad Hosein Farzaei WORLD JOURNAL OF GASTROENTEROLOGY
- Principal Component Analysis of the Effects of Environmental Enrichment and (-)-epigallocatechin-3-gallate on Age-Associated Learning Deficits in a Mouse Model of Down Syndrome
- (2015) Silvina Catuara-Solarz et al. Frontiers in Behavioral Neuroscience
- Emerging Therapeutics for Alzheimer's Disease
- (2014) Karen Chiang et al. Annual Review of Pharmacology and Toxicology
- Diagnosis and classification of psoriasis
- (2014) Smriti K. Raychaudhuri et al. AUTOIMMUNITY REVIEWS
- Having a Promising Efficacy on Type II Diabetes, It’s Definitely a Green Tea Time
- (2014) Hen Jiao et al. CURRENT MEDICINAL CHEMISTRY
- Latest treatment options for Alzheimer’s disease, Parkinson’s disease dementia and dementia with Lewy bodies
- (2014) Martin Broadstock et al. EXPERT OPINION ON PHARMACOTHERAPY
- Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity
- (2014) Cliona Stack et al. HUMAN MOLECULAR GENETICS
- Fibrillar Amyloid- Peptides Activate Microglia via TLR2: Implications for Alzheimer's Disease
- (2014) M. Jana et al. JOURNAL OF IMMUNOLOGY
- Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014
- (2014) L. S. Schneider et al. JOURNAL OF INTERNAL MEDICINE
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Consumption of Green Tea, but Not Black Tea or Coffee, Is Associated with Reduced Risk of Cognitive Decline
- (2014) Moeko Noguchi-Shinohara et al. PLoS One
- Epigallocatechin-3-Gallate Attenuates Impairment of Learning and Memory in Chronic Unpredictable Mild Stress-Treated Rats by Restoring Hippocampal Autophagic Flux
- (2014) Hong-Feng Gu et al. PLoS One
- Green tea extract enhances parieto-frontal connectivity during working memory processing
- (2014) André Schmidt et al. PSYCHOPHARMACOLOGY
- 5-HT6 receptor antagonists as treatment for age-related cognitive decline
- (2014) Anne Quiedeville et al. REVIEWS IN THE NEUROSCIENCES
- The worldwide economic impact of dementia 2010
- (2013) Anders Wimo et al. Alzheimers & Dementia
- Systematic Review: Factors Associated With Risk for and Possible Prevention of Cognitive Decline in Later Life
- (2013) Brenda L. Plassman ANNALS OF INTERNAL MEDICINE
- Epigallocatechin-3-gallate prevents oxidative phosphorylation deficit and promotes mitochondrial biogenesis in human cells from subjects with Down's syndrome
- (2013) Daniela Valenti et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The effect of Chinese Jinzhida recipe on the hippocampus in a rat model of diabetes-associated cognitive decline
- (2013) Xiao-Hui Chang et al. BMC Complementary and Alternative Medicine
- Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans
- (2013) Rafael De la Torre et al. MOLECULAR NUTRITION & FOOD RESEARCH
- A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
- (2013) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Influence of the Green Tea Leaf Extract on Neurotoxicity of Aluminium Chloride in Rats
- (2013) Ankica Jelenković et al. PHYTOTHERAPY RESEARCH
- Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions
- (2013) Geert Jan Biessels et al. Lancet Diabetes & Endocrinology
- Green tea consumption and the risk of incident functional disability in elderly Japanese: the Ohsaki Cohort 2006 Study
- (2012) Yasutake Tomata et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease
- (2012) Vladimir Coric et al. ARCHIVES OF NEUROLOGY
- Green tea (−)epigallocatechin-3-gallate reverses oxidative stress and reduces acetylcholinesterase activity in a streptozotocin-induced model of dementia
- (2012) Regina Biasibetti et al. BEHAVIOURAL BRAIN RESEARCH
- (−)-Epigallocatechin-3-gallate decreases the impairment in learning and memory in spontaneous hypertension rats
- (2012) Mao-Hsien Wang et al. BEHAVIOURAL PHARMACOLOGY
- Structural Properties of EGCG-Induced, Nontoxic Alzheimer's Disease Aβ Oligomers
- (2012) Juan Miguel Lopez del Amo et al. JOURNAL OF MOLECULAR BIOLOGY
- Fruit, vegetables and prevention of cognitive decline or dementia: A systematic review of cohort studies
- (2012) M. Loef et al. Journal of Nutrition Health & Aging
- Green tea and green tea catechin extracts: An overview of the clinical evidence
- (2012) Rachel Johnson et al. MATURITAS
- The ageing cortical synapse: hallmarks and implications for cognitive decline
- (2012) John H. Morrison et al. NATURE REVIEWS NEUROSCIENCE
- Inhibition of acetylcholinesterase by green and white tea and their simulated intestinal metabolites
- (2012) Edward J. Okello et al. Food & Function
- Acute neurocognitive effects of epigallocatechin gallate (EGCG)
- (2011) Andrew Scholey et al. APPETITE
- The Memory Fitness Program: Cognitive Effects of a Healthy Aging Intervention
- (2011) Karen J. Miller et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment
- (2011) Suzanne Craft ARCHIVES OF NEUROLOGY
- Chronic epigallocatechin-3-gallate ameliorates learning and memory deficits in diabetic rats via modulation of nitric oxide and oxidative stress
- (2011) Tourandokht Baluchnejadmojarad et al. BEHAVIOURAL BRAIN RESEARCH
- Amelioration of behavioral aberrations and oxidative markers by green tea extract in valproate induced autism in animals
- (2011) David Banji et al. BRAIN RESEARCH
- Aligning the evidence with practice: NICE guidelines for drug treatment of Alzheimer’s disease
- (2011) Clive Ballard et al. Expert Review of Neurotherapeutics
- A Combination of Green Tea Extract and l-Theanine Improves Memory and Attention in Subjects with Mild Cognitive Impairment: A Double-Blind Placebo-Controlled Study
- (2011) Sang-Ki Park et al. JOURNAL OF MEDICINAL FOOD
- The Second-Generation Active A Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects
- (2011) C. Wiessner et al. JOURNAL OF NEUROSCIENCE
- (−)-Epigallocatechin-3-gallate Protects Against Neuronal Cell Death and Improves Cerebral Function After Traumatic Brain Injury in Rats
- (2011) Tatsuki Itoh et al. NEUROMOLECULAR MEDICINE
- Stress effects on memory: An update and integration
- (2011) Lars Schwabe et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue
- (2011) Julio C. Rojas et al. PROGRESS IN NEUROBIOLOGY
- Anti-TNF-α reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP/PS1 transgenic mouse brains
- (2010) Jian-Quan Shi et al. BRAIN RESEARCH
- Nanolipidic particles improve the bioavailability and α-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease
- (2010) Adam Smith et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Review Article: Genetics of Alzheimer Disease
- (2010) Lynn M. Bekris et al. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
- Synapse loss in dementias
- (2010) Ryan Clare et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Citicoline, use in cognitive decline: Vascular and degenerative
- (2010) Rocío García-Cobos et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Mitochondrial Dysfunction: Common Final Pathway in Brain Aging and Alzheimer’s Disease—Therapeutic Aspects
- (2010) Walter E. Müller et al. MOLECULAR NEUROBIOLOGY
- Alzheimer's disease: strategies for disease modification
- (2010) Martin Citron NATURE REVIEWS DRUG DISCOVERY
- Protective effects of green tea polyphenols on cognitive impairments induced by psychological stress in rats
- (2009) Wei-Qiang Chen et al. BEHAVIOURAL BRAIN RESEARCH
- Long-Term Follow-Up of Patients Immunized with AN1792: Reduced Functional Decline in Antibody Responders
- (2009) Bruno Vellas et al. Current Alzheimer Research
- Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: A link between diabetes and Alzheimer's disease
- (2009) Paula L. McClean et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- -Amyloid Oligomers Induce Phosphorylation of Tau and Inactivation of Insulin Receptor Substrate via c-Jun N-Terminal Kinase Signaling: Suppression by Omega-3 Fatty Acids and Curcumin
- (2009) Q.-L. Ma et al. JOURNAL OF NEUROSCIENCE
- Green Tea (-)-Epigallocatechin-3-Gallate Inhibits β-Amyloid-Induced Cognitive Dysfunction through Modification of Secretase Activity via Inhibition of ERK and NF-κB Pathways in Mice
- (2009) Jae Woong Lee et al. JOURNAL OF NUTRITION
- Green tea polyphenols inhibit cognitive impairment induced by chronic cerebral hypoperfusion via modulating oxidative stress
- (2009) Yan Xu et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Long-term green tea catechin administration prevents spatial learning and memory impairment in senescence-accelerated mouse prone-8 mice by decreasing Aβ1-42 oligomers and upregulating synaptic plasticity–related proteins in the hippocampus
- (2009) Q. Li et al. NEUROSCIENCE
- The potential role of green tea catechins in the prevention of the metabolic syndrome – A review
- (2009) Frank Thielecke et al. PHYTOCHEMISTRY
- Green Tea Catechin Polyphenols Attenuate Behavioral and Oxidative Responses to Intermittent Hypoxia
- (2008) Isabel C. Burckhardt et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Cyclooxygenase-2 inhibition improves amyloid-β-mediated suppression of memory and synaptic plasticity
- (2008) Linda A. Kotilinek et al. BRAIN
- Green tea epigallocatechin-3-gallate (EGCG) reduces β-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice
- (2008) Kavon Rezai-Zadeh et al. BRAIN RESEARCH
- Safety of Green Tea Extracts
- (2008) Dandapantula N Sarma et al. DRUG SAFETY
- Effects of green tea extract on learning, memory, behavior and acetylcholinesterase activity in young and old male rats
- (2007) Tranum Kaur et al. BRAIN AND COGNITION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More